The process development laboratory will be located at ACG’s XERTECS site in Mulheim, southwest Germany
Global pharmaceutical company ACG has announced the launch of a process development laboratory, to be built in southwest Germany.
The aim of ACG's new laboratory will be to provide its customers with the latest knowledge, skills and equipment.
This comes after the success of ACG's first-to-market laboratory for process development in India.
Speaking about the new project, ACG Engineering's Chief Executive Officer, Dr Marcus Michel, said: "ACG's process labs reinforce our commitment to 'making it better'. Requested by the Indian market, our first lab has enabled customers to build their competencies and capabilities, as well as to scale up - with many of these customers now operating at high capacity and efficiency.
According to the company, ACG's new laboratory is to remain consistent with the first - to provide customers and partners access to the latest knowledge, skills and equipment to collaboratively keep pushing the boundaries of all aspects of process development.
Customers can continue to test solid dosage optimisation limits, for example, and co-create alongside ACG's team of experts to develop new process solutions.
"Our plan is simply to replicate this model in the European market, and we are working at full speed to ensure the launch of our new facility in 2023," said Dr Michel.
He continued: "The lab in India is home to some of the smartest and finest technologies in powder processing, and is fully equipped for all aspects of granulation, drying, tablet compression and coating. Many of our machines are unique because they have been built or modified in direct response to our customer's needs - helping them on their manufacturing journey.